Showing results (601-610 of 3,171) with videos related to

Sort By:
Pageof 318
Translational Oncology|May 20, 2025
Targeting EPAS-1/HIF-2α Pathway to Address Endocrine Resistance in Luminal A Type Breast CancerEnzhi Luo, Seongmin Lee, Neeraj Manvi Agarwal, et al.
Translational Oncology|May 18, 2025
KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinomaAnalia Meilerman Abuelafia, Patricia Santofimia-Castaño, Matias Estaras, et al.
Translational Oncology|May 13, 2025
Therapeutic advances and application of PARP inhibitors in breast cancerTeng Zhou, Jian Zhang
Translational Oncology|May 27, 2025
Unveiling the multifaceted functions of TRIM proteins in glioma pathogenesisWenjie Wu, Youxi Xie, Cheng Jiang, et al.
Translational Oncology|May 27, 2025
Cucurbitacin B induces oral squamous cell carcinomapyroptosis via GSDME and inhibits tumour growthXin Chen, Mengyuan Yang, Heng Zhang, et al.
Translational Oncology|May 27, 2025
USP35 promotes hepatocellular carcinoma proliferation through GASC1-mediated ROCK2 upregulationGen Chen, Yong Shi, Shuaimin Zhang, et al.
Translational Oncology|May 22, 2025
RIP2/NF-κB/PD-L1 signaling pathway is involved in temozolomide resistance by inducing autophagy in glioblastoma cellsXiaomeng Liu, Xiaosong Liu, Lei Zhao, et al.
Translational Oncology|July 10, 2025
Novel multi-omics analysis revealing metabolic heterogeneity of breast cancer cell and subsequent development of associated prognostic signaturePeng Zhang, Cuicui Li, Fen Li, et al.
Translational Oncology|July 17, 2025
Immune-checkpoint inhibition for tumor prevention in a preclinical Lynch syndrome modelAnnabell Wolff, Johanna Maennicke, Maja Huehns, et al.
Translational Oncology|July 25, 2025
Expanded and activated marrow-infiltrating lymphocytes exhibit potent antimyeloma activity against autologous multiple myeloma cellsSeo-Yeon Ahn, Manh-Cuong Vo, Van-Tan Nguyen, et al.
Pageof 318